Skip to content
value.today

Acro Biomedical Co., Ltd. vs Moderna, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Moderna, Inc. is the larger company by market value: $90.1 B against $240 M for Acro Biomedical Co., Ltd., 376 times as much (market caps of Dec 25, 2022 for Acro Biomedical Co., Ltd. and Oct 30, 2026 for Moderna, Inc.). Acro Biomedical Co., Ltd.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.
  • Both made a net loss: $0 M for Acro Biomedical Co., Ltd. and $2.8 B for Moderna, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0342685102713702020202120222023202420252026Acro Biomedical Co., Ltd. 138Moderna, Inc. 1370

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$5B$10B$14B$19B201720182019202020212022202320242025Acro Biomedical Co., Ltd. $0BModerna, Inc. $2B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAcro Biomedical Co., Ltd.
ACBM
Moderna, Inc.
MRNA · #274 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded20142010
Size
Market cap$240 M*$90.1 B
Revenue—$1.9 B
Net income$-0 M▲ best$-2.8 B
Employees—4,700
Valuation
Price to sales—35.7×
Price to book—10.4×
Free cash flow yield—-2.3%
Profitability
Gross margin—55.4%
Operating margin—-158.1%
Net margin—-145.2%
Return on equity—-28.9%
Growth
Revenue growth—-39.9%
Revenue growth, 3 years a year—-53.4%
Financial strength
Debt to equity—0.1×
Cash
Free cash flow margin—-106.2%
Shareholder returns
Shareholder yield—0.0%
Strength scores
Piotroski F-score—3 of 9
Altman Z-score zone—safe
Data as ofMarket cap Dec 2022; ratios FY2025Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Acro Biomedical Co., Ltd. or Moderna, Inc.?

Moderna, Inc. is the larger company by market value: $90.1 B against $240 M for Acro Biomedical Co., Ltd., 376 times as much (market caps of Dec 25, 2022 for Acro Biomedical Co., Ltd. and Oct 30, 2026 for Moderna, Inc.). Acro Biomedical Co., Ltd.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.

Which makes more money, Acro Biomedical Co., Ltd. or Moderna, Inc.?

Both made a net loss: $0 M for Acro Biomedical Co., Ltd. and $2.8 B for Moderna, Inc.